GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » EV-to-FCF

Decipher Labs (BOM:524752) EV-to-FCF : (As of May. 23, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Decipher Labs's Enterprise Value is ₹64.4 Mil. Decipher Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.0 Mil. Therefore, Decipher Labs's EV-to-FCF for today is .

The historical rank and industry rank for Decipher Labs's EV-to-FCF or its related term are showing as below:

BOM:524752' s EV-to-FCF Range Over the Past 10 Years
Min: -5.76   Med: 0   Max: 97.36
Current: -2.75

During the past 13 years, the highest EV-to-FCF of Decipher Labs was 97.36. The lowest was -5.76. And the median was 0.00.

BOM:524752's EV-to-FCF is ranked worse than
100% of 524 companies
in the Drug Manufacturers industry
Industry Median: 25.35 vs BOM:524752: -2.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Decipher Labs's stock price is ₹14.93. Decipher Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-194.940. Therefore, Decipher Labs's PE Ratio for today is At Loss.


Decipher Labs EV-to-FCF Historical Data

The historical data trend for Decipher Labs's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs EV-to-FCF Chart

Decipher Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.76 -1.65 28.45 6.00 -3.35

Decipher Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.35 - - -

Competitive Comparison of Decipher Labs's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Decipher Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decipher Labs's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Decipher Labs's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Decipher Labs's EV-to-FCF falls into.



Decipher Labs EV-to-FCF Calculation

Decipher Labs's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=64.427/0
=

Decipher Labs's current Enterprise Value is ₹64.4 Mil.
Decipher Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs  (BOM:524752) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Decipher Labs's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.93/-194.940
=At Loss

Decipher Labs's share price for today is ₹14.93.
Decipher Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-194.940.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Decipher Labs EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Decipher Labs's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs (BOM:524752) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs (BOM:524752) Headlines

No Headlines